Immunotherapy For Lung Cancer
Immunotherapy
for lung cancer

Immunotherapy for Stage IV NSCLC

Stage IV (metastatic) non-small cell lung cancer (NSCLC) means the tumor has spread to other sites of the body. First-line treatment options include radiation therapy, chemotherapy, immunotherapy and targeted therapy which targets the biomarkers in cancer cells.42

Immunotherapy is available to help patients live longer with improved quality of life. Several immunotherapy agents are now approved by the Department of Health for patients with stage IV NSCLC. Depending on the patient condition, some of the PD-1 and PD-L1 inhibitors can be used as first-line or later lines of therapy.28

Stage IV non-small cell lung cancer has many different treatment approaches. Doctors will choose the suitable treatments for patients based on their conditions.

Subscribe